(Q34228066)

31 July 2017

title

Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients. (English)

1 reference

31 July 2017

K B Lundin

1

1 reference

31 July 2017

M Henningson

2

1 reference

31 July 2017

M Hietala

3

1 reference

31 July 2017

C Ingvar

4

1 reference

31 July 2017

C Rose

5

1 reference

31 July 2017

H Jernström

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

27 October 2011

1 reference

British Journal of Cancer

31 July 2017

published in

1 reference

31 July 2017

volume

105

1 reference

31 July 2017

issue

11

1 reference

31 July 2017

page(s)

1676-1683

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2011.441

31 July 2017

exact match

0 references

cites work

Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Androgen receptor expression and breast cancer survival in postmenopausal women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Pharmacogenetics of endocrine therapy for breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention Trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Benefits and adverse effects of endocrine therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

The optimal cutoff values and their performance of waist circumference and waist-to-hip ratio for diagnosing type II diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Genotype-guided tamoxifen therapy: time to pause for reflection?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Of cup and bra size: reply to a prospective study of breast size and premenopausal breast cancer incidence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Aromatase and the breast: regulation and clinical aspects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Chemistry and structural biology of androgen receptor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Postmenopausal testosterone therapy and breast cancer risk.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Obesity, Tamoxifen Use, and Outcomes in Women With Estrogen Receptor-Positive Early-Stage Breast Cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Adjusting for multiple testing--when and how?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Interactions between androgen and estrogen receptors and the effects on their transactivational properties

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Hormonal control of regional fat distribution

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242599

Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status

5 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.441

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety upda

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.441

Increased 5α-reductase type 2 expression in human breast carcinoma following aromatase inhibitor therapy: the correlation with decreased tumor cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.441

A single-nucleotide polymorphism in the aromatase gene is associated with the efficacy of the aromatase inhibitor letrozole in advanced breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.441

21 January 2018

Androgens and the breast

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.441

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.441

Obesity and hormone therapy in breast cancer: an unfinished puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.441

Long-term benefits of 5 years of tamoxifen: 10-year follow-up of a large randomized trial in women at least 50 years of age with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.441

Expression of androgen receptors in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.441

The GGN and CAG repeat polymorphisms in the exon-1 of the androgen receptor gene are, respectively, associated with insulin resistance in men and with dyslipidemia in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.441

Predictors of response to exemestane as primary endocrine therapy in estrogen receptor-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.441

Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.441

Germ-Line Genetic Variation in the Key Androgen-Regulating Genes Androgen Receptor, Cytochrome P450, and Steroid-5- -Reductase Type 2 Is Important for Prostate Cancer Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.441

Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families

21 January 2018

1 reference

12 December 2020

Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial

1 reference

12 December 2020

Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy

1 reference

12 December 2020

Linkage between androgen receptor gene CAG trinucleotide repeat length and testicular germ cell cancer histological type and clinical stage

1 reference

12 December 2020

Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2011.441

1 reference

Dimensions Publication ID

31 July 2017

1050120722

0 references

Fatcat ID

release_xsquhkxh7rg4zah7cuxnt2ib4m

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xsquhkxh7rg4zah7cuxnt2ib4m

24 November 2022

mapped directly with Wikidata item

PMC publication ID

3242599

1 reference

31 July 2017

1 reference